A clinician interview published by Hartford HealthCare draws a hard line between peptide medications that have been through clinical review and the peptide injections sold online for recovery, sleep and body composition. Joe Li, DO, of Hartford HealthCare Medical Group, says peptide therapy "can mean many different things, and not every product comes with the same level of research or oversight."

Peptides are short chains the body makes on its own to let systems talk to each other, involved in appetite, blood sugar, growth and metabolism. Peptide drugs are built to copy or influence those existing signals, which is why the category covers everything from insulin to GLP-1 medications such as semaglutide and tirzepatide, and also a nasal spray sold by a wellness clinic with no trial behind it.

What approval actually covers

The point Li keeps returning to is that FDA approval attaches to a specific medication for a specific use, not to the word peptide. For approved products, he says, there is guidance on dosing, side effects and which patients may benefit. That guidance does not transfer sideways to an injection that happens to share a chemical class.

He also notes that even an approved treatment can carry risks or be wrong for a given patient, which is why he frames prescribing as something that follows a review of health history and goals.

The compounds sold online

The article names the ones the wellness market actually moves: BPC-157, marketed for tendon, ligament and muscle injuries, and ipamorelin and CJC-1295, promoted for growth hormone, muscle and signs of aging. None of these, Li says, have been supported by the level of human research an approved drug requires. Much of the available work sits in labs or animals.

That is the sentence most peptide marketing is built to avoid, and it is worth saying plainly. Findings in one peptide also cannot be borrowed to vouch for another. Each product stands on its own evidence, and stacking several at once compounds the uncertainty because the combination has no established dose or safety record.

What is in the vial

Li raises a second problem that has nothing to do with efficacy: compounded products are not FDA-approved and do not go through the same review, and poor compounding can mean contamination or wrong amounts of active ingredient. Labels reading "research use only" or "not for human consumption" are flagged as warning signs.

Bottom line

The advice in the piece is to start with the symptom rather than the product, since fatigue, poor sleep and slow recovery have many causes. Li suggests asking whether something is FDA-approved for your condition, what research supports it, and how side effects will be monitored.